SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Andrea Filippi

Andrea Filippi

Istituto Nazionale dei Tumori, Milan

Prof. Andrea Riccardo Filippi heads the Radiation Oncology Unit at the Fondazione IRCCS Istituto Nazionale dei Tumori in Milan and is Associate Professor of Radiotherapy in the Department of Oncology at the University of Milan. His thoracic work centers on stereotactic body radiotherapy and the integration of radiotherapy with immunotherapy in non-small cell lung cancer, including consolidation durvalumab after chemoradiation in stage III disease. He contributes to international guidance through ESTRO, IASLC, and ESMO, including the IASLC Advanced Radiation Technology Subcommittee and an ESTRO clinical practice guideline on radiation-induced pneumonitis. He is a frequent speaker at major international thoracic oncology congresses.

Connect

Andrea Filippi

Featured in

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates